We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Nosocomial Amphotericin B Current Status

Arch Intern Med. 1989;149(11):2402-2403. doi:10.1001/archinte.1989.00390110008002.
Text Size: A A A
Published online


Fungal diseases are relative newcomers among infectious diseases. Even though the major endemic mycoses, coccidioidomycosis, blastomycosis, See also p 2533. and histoplasmosis, were recognized around the turn of the 20th century, they remained medical curiosities until just after World War II. Our understanding of these extremely common infections continued to expand until, by the middle 1950s, both coccidioidomycosis and histoplasmosis became well understood, and only the natural history of the much more uncommon blastomycosis remained poorly charted.

Simultaneously with our expanding understanding of diseases caused by these usually pathogenic fungi, infections caused by fungi of low natural invasiveness began to appear in special patient populations.

Recognition of life-threatening illnesses caused by these saprophytic fungi closely followed the advent of the modern era of cancer chemotherapy. From the introduction of mechlorethamine hydrochloride (nitrogen mustard) into clinical practice, an ever increasing torrent of new, more and more potent antineoplastic agents appeared, ushering


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

4 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.